Market Value101,927,543
Total Holdings59
File Date2025-08-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ANIP / ANI Pharmaceuticals, Inc.
HCAT / Health Catalyst, Inc.
LQDA / Liquidia Corporation
INDV / Indivior PLC
THRD / Third Harmonic Bio, Inc.
URGN / UroGen Pharma Ltd.
AADI / Aadi Bioscience, Inc.
XGN / Exagen Inc.
OPTN / OptiNose, Inc.
NKTX / Nkarta, Inc.
PROF / Profound Medical Corp.
SCPH / scPharmaceuticals Inc.
ACET / Adicet Bio, Inc.
PYPD / PolyPid Ltd.
INO / Inovio Pharmaceuticals, Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
KROS / Keros Therapeutics, Inc.
ELAN / Elanco Animal Health Incorporated
SEPN / Septerna, Inc.
RNXT / RenovoRx, Inc.
HLVX / HilleVax, Inc.
SRZN / Surrozen, Inc.
INAB / IN8bio, Inc.
BOLD / Boundless Bio, Inc.
ESPR / Esperion Therapeutics, Inc.
IMAB / I-Mab - Depositary Receipt (Common Stock)
IOVA / Iovance Biotherapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
GRCE / Grace Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
COLL / Collegium Pharmaceutical, Inc.
XOMA / XOMA Royalty Corporation
RZLT / Rezolute, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
GERN / Geron Corporation
SVRA / Savara Inc.
ANTX / AN2 Therapeutics, Inc.
THTX / Theratechnologies Inc.
PMVP / PMV Pharmaceuticals, Inc.
DVAX / Dynavax Technologies Corporation
EOLS / Evolus, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
ESTA / Establishment Labs Holdings Inc.
AYTU / Aytu BioPharma, Inc.
ZVRA / Zevra Therapeutics, Inc.
VIR / Vir Biotechnology, Inc.
HRTX / Heron Therapeutics, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
ADMA / ADMA Biologics, Inc.
IKT / Inhibikase Therapeutics, Inc.
TELA / TELA Bio, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
ITOS / iTeos Therapeutics, Inc.
KPRX / Kiora Pharmaceuticals, Inc.
SPRO / Spero Therapeutics, Inc.
ANIK / Anika Therapeutics, Inc.
VNDA / Vanda Pharmaceuticals Inc.
KZR / Kezar Life Sciences, Inc.
BIOA / BioAge Labs, Inc.
XERS / Xeris Biopharma Holdings, Inc.
CHRS / Coherus Oncology, Inc.
EDSA / Edesa Biotech, Inc.
AQST / Aquestive Therapeutics, Inc.
AMARIN CORP PLC / SPONS ADR NEW (023111206)
EBS / Emergent BioSolutions Inc.
SLRN / Acelyrin, Inc.
CRGX / CARGO Therapeutics, Inc.
APRE / Aprea Therapeutics, Inc.
MYO / Myomo, Inc.
MIST / Milestone Pharmaceuticals Inc.
ACHV / Achieve Life Sciences, Inc.
ALMS / Alumis Inc.
ELYM / Eliem Therapeutics, Inc.
NKTR / Nektar Therapeutics
KURA / Kura Oncology, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
ANGO / AngioDynamics, Inc.
ARDX / Ardelyx, Inc.
VSTM / Verastem, Inc.
VSTM / Verastem, Inc. Call
GLUE / Monte Rosa Therapeutics, Inc.
NUVB / Nuvation Bio Inc.
CALC / CalciMedica, Inc.
ABEO / Abeona Therapeutics Inc.
LUNG / Pulmonx Corporation